Northwest Drug Testing. (Industry News).

Drug Detection Report, November, 2002

NORTHWEST DRUG TESTING'S parent company, NWT Inc., has signed a letter of intent with 4netSoftware Inc. to effect a share exchange agreement. The name of 4net will be changed to NWT Inc. with NWT's current officers and managers to continue operating the company and its existing policies. Steven Bronson, CEO of 4net, will become a member of the NWT board.

Northwest Drug Testing Vice President and General Manager Michael Feldman said: "This contemplated transaction will enable our drug-testing division to remain an independent laboratory service provider for the foreseeable future." The finalization of the transaction is expected Dec. 31. Contact Sheran Smith, NWT vice president for corporate affairs, (801) 293-2300, e-mail: sheran@nwtinc.com.